Report cover image

Japan Immunoassay Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Kits, Analyzers/Instruments), By Technology, By Specimen, By Application, By End Use – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Aug 01, 2025
Length 129 Pages
SKU # PLRS20381469

Description

The japan immunology market size is expected to reach USD 2.61 billion by 2034, according to a new study by Polaris Market Research. The report “Japan Immunoassay Market Share, Size, Trends, Industry Analysis Report By Product (Reagents & Kits, Analyzers/Instruments), By Technology, By Specimen, By Application, By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Immunology is the scientific discipline that focuses on understanding the body’s defense mechanisms against pathogens and abnormal cells through immune system responses. The Japan immunology market growth is driven by the growing adoption of targeted biologic therapies, which are transforming treatment paradigms for autoimmune and inflammatory conditions. These therapies offer greater precision and reduced side effects compared to conventional immunosuppressants, aligning with Japan’s ongoing efforts to enhance patient outcomes through advanced and individualized care. Biologics continue to gain momentum, strengthening their role in modern immunology practices as the demand for more effective and disease-specific treatments rises.

The Japan immunoassay market growth is attributed to the integration of digital health technologies in immunological research and patient management. Tools such as electronic health records, artificial intelligence in diagnostics, and remote monitoring systems are streamlining clinical workflows and supporting data-driven decision-making. These digital advancements improve patient tracking and treatment adherence and also facilitate personalized therapy adjustments based on real-time immune response data. Therefore, as Japan’s healthcare ecosystem increasingly adopts these technologies, the immunoassay market in Japan is expected to benefit from improved efficiency, better clinical insights, and more tailored treatment pathways.

Japan Immunoassay Market Report Highlights

In terms of product, the reagents & kits segment generated USD 1.01 billion in 2024 revenue, due to essential recurring use across clinical labs and research institutions.

Based on technology, the rapid test segment is projected to register a CAGR of 5.0%, reflecting Japan's healthcare shift toward point-of-care testing and preventive medicine solutions.

A few global key market players include FUJIFILM Wako Pure Chemical Corporation; Fujirebio (H.U. Group Holdings/Fujirebio Inc.); Hitachi, Ltd.; Kyowa Hakko Kirin (Kyowa Kirin Co., Ltd.); LSI Medience Corporation; Nihon Kohden Corporation; Nippon Kayaku Co., Ltd.; Shimadzu Corporation; Sysmex Corporation; and Tosoh Corporation (Tosoh Bioscience).

Polaris Market Research has segmented the Japan immunoassay market report on the basis of product, technology, specimen, application, and end use:

By Product Outlook (Revenue, USD Billion, 2020–2034)

Reagents & Kits

ELISA Reagents & Kits

Rapid Test Reagents & Kits

Western Blot Reagents & Kits

ELISPOT Reagents & Kits

Other Reagents & Kits

Analyzers/Instruments

Open Ended Systems

Closed Ended Systems

Software & Services

By Technology Outlook (Revenue, USD Billion, 2020–2034)

Enzyme Immunoassays (EIA)

Chemiluminescence Immunoassays (CLIA)

Fluorescence Immunoassays (FIA)

Rapid Test

Radioimmunoassay (RIA)

Others

By Specimen Outlook (Revenue, USD Billion, 2020–2034)

Blood

Urine

Saliva

Others

By Application Outlook (Revenue, USD Billion, 2020–2034)

Infectious Disease Testing

Cardiology

Oncology

Endocrinology

Autoimmune Diseases

Therapeutic Drug Monitoring

Others

By End Use Outlook (Revenue, USD Billion, 2020–2034)

Hospitals

Laboratories

Others

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Retail and E-Commerce
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Japan Immunoassay Market Insights
4.1. Japan Immunoassay Market – Material Snapshot
4.2. Japan Immunoassay Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Prevalence of Chronic Diseases and Cancer
4.2.1.2. Rising Innovations in Immunoassay Technology
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory Challenges and Market Fragmentation
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Japan Immunoassay Market Material Trends
4.6. Value Chain Analysis
5. Japan Immunoassay Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Japan Immunoassay Market, by Product, 2020-2034 (USD Billion)
5.3. Reagents & Kits
5.3.1. Japan Immunoassay Market, by Reagents & Kits, 2020–2034 (USD Billion)
5.3.2. ELISA Reagents & Kits
5.3.2.1. Japan Immunoassay Market, by ELISA Reagents & Kits, 2020–2034 (USD Billion)
5.3.3. Rapid Test Reagents & Kits
5.3.3.1. Japan Immunoassay Market, by Rapid Test Reagents & Kits, 2020–2034 (USD Billion)
5.3.4. Western Blot Reagents & Kits
5.3.5. Japan Immunoassay Market, by Western Blot Reagents & Kits, 2020–2034 (USD Billion)
5.3.6. ELISPOT Reagents & Kits
5.3.6.1. Japan Immunoassay Market, by ELISPOT Reagents & Kits, 2020–2034 (USD Billion)
5.3.7. Other Reagents & Kits
5.3.7.1. Japan Immunoassay Market, by Other Reagents & Kits, 2020–2034 (USD Billion)
5.4. Analyzers/Instruments
5.4.1. Japan Immunoassay Market, by Analyzers/ Instruments, 2020–2034 (USD Billion)
5.4.2. Open Ended Systems
5.4.2.1. Japan Immunoassay Market, by Open Ended Systems, 2020–2034 (USD Billion)
5.4.3. Closed Ended Systems
5.4.3.1. Japan Immunoassay Market, by Closed Ended Systems, 2020–2034 (USD Billion)
5.5. Software & Services
5.5.1. Japan Immunoassay Market, by Software & Services, 2020–2034 (USD Billion)
6. Japan Immunoassay Market, Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Japan Immunoassay Market, Technology, 2020-2034 (USD Billion)
6.3. Enzyme Immunoassays (EIA)
6.3.1. Japan Immunoassay Market, by Enzyme Immunoassays (EIA), 2020–2034 (USD Billion)
6.3.2. Chemiluminescence Immunoassays (CLIA)
6.3.2.1. Japan Immunoassay Market, by Chemiluminescence Immunoassays (CLIA), 2020–2034 (USD Billion)
6.3.3. Fluorescence Immunoassays (FIA)
6.3.3.1. Japan Immunoassay Market, by Fluorescence Immunoassays (FIA), 2020–2034 (USD Billion)
6.4. Rapid Test
6.4.1. Japan Immunoassay Market, by Rapid Test, 2020–2034 (USD Billion)
6.5. Radioimmunoassay (RIA)
6.5.1. Japan Immunoassay Market, by Radioimmunoassay (RIA), 2020–2034 (USD Billion)
6.6. Others
6.6.1. Japan Immunoassay Market, by Others, 2020–2034 (USD Billion)
7. Japan Immunoassay Market, by Specimen
7.1. Key Findings
7.2. Introduction
7.2.1. Japan Immunoassay Market, by Specimen, 2020-2034 (USD Billion)
7.3. Blood
7.3.1. Japan Immunoassay Market, by Blood, 2020–2034 (USD Billion)
7.4. Urine
7.4.1. Japan Immunoassay Market, by Urine, 2020–2034 (USD Billion)
7.5. Saliva
7.5.1. Japan Immunoassay Market, by Saliva, 2020–2034 (USD Billion)
7.6. Others
7.6.1. Japan Immunoassay Market, by Others, 2020–2034 (USD Billion)
8. Japan Immunoassay Market, by Application
8.1. Key Findings
8.2. Introduction
8.2.1. Japan Immunoassay Market, by Application, 2020-2034 (USD Billion)
8.3. Infectious Disease Testing
8.3.1. Japan Immunoassay Market, by Infectious Disease Testing, 2020–2034 (USD Billion)
8.4. Cardiology
8.4.1. Japan Immunoassay Market, by Cardiology, 2020–2034 (USD Billion)
8.5. Oncology
8.5.1. Japan Immunoassay Market, by Oncology, 2020–2034 (USD Billion)
8.6. Endocrinology
8.6.1. Japan Immunoassay Market, by Endocrinology, 2020–2034 (USD Billion)
8.7. Autoimmune Diseases
8.7.1. Japan Immunoassay Market, by Autoimmune Diseases, 2020–2034 (USD Billion)
8.8. Therapeutic Drug Monitoring
8.8.1. Japan Immunoassay Market, by Therapeutic Drug Monitoring, 2020–2034 (USD Billion)
8.9. Others
8.9.1. Japan Immunoassay Market, by Others, 2020–2034 (USD Billion)
9. Japan Immunoassay Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. Japan Immunoassay Market, by End Use, 2020-2034 (USD Billion)
9.3. Hospitals
9.3.1. Japan Immunoassay Market, by Hospitals, 2020-2034 (USD Billion)
9.4. Laboratories
9.4.1. Japan Immunoassay Market, by Laboratories, 2020-2034 (USD Billion)
9.5. Others
9.5.1. Japan Immunoassay Market, by Others, 2020-2034 (USD Billion)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. FUJIFILM Wako Pure Chemical Corporation
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Fujirebio (H.U. Group Holdings/Fujirebio Inc.)
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Hitachi, Ltd.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Kyowa Hakko Kirin (Kyowa Kirin Co., Ltd.)
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. LSI Medience Corporation
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Nihon Kohden Corporation
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Nippon Kayaku Co., Ltd.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Shimadzu Corporation
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Sysmex Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Tosoh Corporation (Tosoh Bioscience)
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us